SIC
STOK icon

SJS Investment Consulting’s Stoke Therapeutics STOK Stock Holding History

SJS Investment Consulting’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$328 Buy
+10
New +$321 ﹤0.01% 2377

Other funds holding STOK

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
GIM
Generali Investments Management Ljubljana, Slovenia $460M AUM 29.43% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $163M AUM 68.53% 1-Year Est. Return

SJS Investment Consulting's STOK Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in Stoke Therapeutics (STOK) in Q2 2026: 10 shares worth $328. The stake represents ﹤0.01% of the portfolio and ranks #2377 among its holdings.

25 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • SJS Investment Consulting held 10 shares of Stoke Therapeutics worth $328 as of Q2 2026.
  • Stoke Therapeutics was a new SJS Investment Consulting position in Q2 2026.
  • Stoke Therapeutics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2377 holding.
  • 25 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.